Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R8PE
|
|||
| Former ID |
DIB002930
|
|||
| Drug Name |
Pivagabine
|
|||
| Synonyms |
4-Pivalamidobutanoic acid; 69542-93-4; 4-[(2,2-dimethylpropanoyl)amino]butanoic acid; UNII-C53SV0WO4V; Pivagabine [INN]; C53SV0WO4V; Pivagabine (INN); NCGC00160457-01; 4-(2,2-dimethylpropanamido)butanoic acid; 4-[(2,2-dimethylpropionyl)amino]butyric acid; DSSTox_CID_26162; DSSTox_RID_81393; DSSTox_GSID_46162; 4-(2,2-DIMETHYLPROPIONYLAMINO)BUTYRIC ACID; Tonerg; CAS-69542-93-4; 4-((2,2-Dimethylpropionyl)amino)butyric acid; SR-01000945179; CXB-722; EINECS 274-038-3; N-Trimethylacetyl-4-aminobutyric acid; CXB-722; CXB722
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Anxiety disorder [ICD-11: 6B00-6B0Z] | Phase 1 | [1] | |
| Depression [ICD-11: 6A70-6A7Z] | Phase 1 | [1] | ||
| Company |
CeNeRx BioPharma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H17NO3
|
|||
| Canonical SMILES |
CC(C)(C)C(=O)NCCCC(=O)O
|
|||
| InChI |
1S/C9H17NO3/c1-9(2,3)8(13)10-6-4-5-7(11)12/h4-6H2,1-3H3,(H,10,13)(H,11,12)
|
|||
| InChIKey |
SRPNQDXRVRCTNK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 69542-93-4
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:134834
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00814931) Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.